(VIANEWS) – The NASDAQ ended the session with Castle Biosciences (CSTL) rising 6.37% to $27.06 on Wednesday while NASDAQ jumped 1.58% to $11,897.65.
Today’s last reported volume for Castle Biosciences is 148213, 60.86% below its average volume of 378701.
Castle Biosciences’s last close was $25.44, 67.63% under its 52-week high of $78.58.
The company’s growth estimates for the ongoing quarter and the next is a negative 114.3% and a negative 68.1%, respectively.
Castle Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 44.7%, now sitting on 94.08M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Castle Biosciences’s stock is considered to be overbought (>=80).
Castle Biosciences’s Stock Yearly Top and Bottom Value
Castle Biosciences’s stock is valued at $27.06 at 18:36 EST, way under its 52-week high of $78.58 and way higher than its 52-week low of $15.58.
Castle Biosciences’s Moving Average
Castle Biosciences’s value is way above its 50-day moving average of $20.98 and way below its 200-day moving average of $39.80.
More news about Castle Biosciences (CSTL).